The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for elderly patients with CCR4-positive adult T-cell leukemia/lymphoma.
 
Ilseung Choi
No Relationships to Disclose
 
Makoto Yoshimitsu
Honoraria - Daiichi Sankyo; Novartis; Sanofi; Takeda
Consulting or Advisory Role - Takeda
 
Shigeru Kusumoto
Honoraria - Chugai Pharma; Daiichi Sankyo/UCB Japan; Kyowa Kirin Co., Ltd.
Research Funding - Chugai Pharma; Daiichi Sankyo/UCB Japan; Kyowa Kirin Co., Ltd.
 
Mototsugu Shimokawa
No Relationships to Disclose
 
Atae Utsunomiya
Honoraria - Bristol-Myers Squibb Japan; Meiji Seika Kaisha
Consulting or Advisory Role - JIMRO; Otsuka
 
Youko Suehiro
No Relationships to Disclose
 
Tomonori Hidaka
No Relationships to Disclose
 
Kisato Nosaka
Honoraria - Abbvie; Bristol-Myers Squibb Japan; Daiichi Sankyo; Eisai; Janssen; Kyowa Kirin; Meiji Seika Kaisha
Consulting or Advisory Role - Kyowa Kirin
Research Funding - Chugai Pharma; Kyowa Kirin
 
Hidenori Sasaki
No Relationships to Disclose
 
Shinya Rai
Speakers' Bureau - Chugai Pharma; Janssen; Ono Pharmaceutical
 
Shinobu Tamura
No Relationships to Disclose
 
Satsuki Owatari
No Relationships to Disclose
 
Ki-Ryang Koh
No Relationships to Disclose
 
Daisuke Nakamura
Honoraria - Abbvie; Asahi Kasei; Chugai Pharma; Janssen; Meiji Seika Kaisha; Nippon Shinyaku; Sanofi; Takeda
 
Masahito Tokunaga
No Relationships to Disclose
 
Masaaki Sekine
No Relationships to Disclose
 
Yuma Sakamoto
No Relationships to Disclose
 
Hiroshi Inagaki
No Relationships to Disclose
 
Takashi Ishida
No Relationships to Disclose
 
Kenji Ishitsuka
Honoraria - Abbvie; Astellas Pharma; Bristol-Myers Squibb Japan; Celgene; Chugai Pharma; CSL Behring; Daiichi Sankyo; Eisai; Janssen; Kyowa Kirin; Meiji Seika Kaisha; Nippon Shinyaku; Ono Pharmaceutical; Otsuka; Pfizer; Sanofi; Takeda; Yakult Honsha
Consulting or Advisory Role - Daiichi Sankyo; Meiji Seika Kaisha
Research Funding - Asahi Kasei (Inst); Chugai Pharma (Inst); Dainippon Sumitomo Pharma (Inst); Eisai (Inst); Japan Blood Products Organization (Inst); Kyowa Kirin; Mochida Pharmaceutical Co. Ltd. (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)